Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Preferred Shares	Common Shares	Common Shares	Accumulated Other Comprehensive Loss	Accumulated Deficit
Preferred shares, beginning balance (in shares) at Dec. 31, 2024		0
Beginning balance, shareholders' equity at Dec. 31, 2024	$ 39,315	$ 0		$ 497,957	$ (1,821)	$ (456,821)
Common shares, beginning balance (in shares) at Dec. 31, 2024			2,545,342
Issuance of common shares (in shares)			21,045
Issuance of common shares for at-the-market offering, net	108			108
Issuance of common shares for vested restricted stock units (in shares)			751
Shares Issued, Warrants Exercised			50,700
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	71			71
Other Comprehensive Income (Loss), Net of Tax	(3)				(3)
Net income (loss)	(8,785)					(8,785)
Preferred shares, ending balance (in shares) at Mar. 31, 2025		0
Ending balance, shareholders' equity at Mar. 31, 2025	30,706	$ 0		498,136	(1,824)	(465,606)
Common shares, ending balance (in shares) at Mar. 31, 2025			2,617,838
Preferred shares, beginning balance (in shares) at Dec. 31, 2024		0
Beginning balance, shareholders' equity at Dec. 31, 2024	$ 39,315	$ 0		497,957	(1,821)	(456,821)
Common shares, beginning balance (in shares) at Dec. 31, 2024			2,545,342
Issuance of common shares (in shares)	21,045
Issuance of common shares for at-the-market offering, net	$ 100
Other Comprehensive Income (Loss), Net of Tax	14
Net income (loss)	(7,118)
Preferred shares, ending balance (in shares) at Jun. 30, 2025		0
Ending balance, shareholders' equity at Jun. 30, 2025	32,708	$ 0		498,454	(1,807)	(463,939)
Common shares, ending balance (in shares) at Jun. 30, 2025			2,795,056
Preferred shares, beginning balance (in shares) at Mar. 31, 2025		0
Beginning balance, shareholders' equity at Mar. 31, 2025	$ 30,706	$ 0		498,136	(1,824)	(465,606)
Common shares, beginning balance (in shares) at Mar. 31, 2025			2,617,838
Issuance of common shares (in shares)	0
Issuance of common shares for at-the-market offering, net	$ 0
Issuance of common shares for vested restricted stock units (in shares)			68,518
Shares Issued, Warrants Exercised			108,700
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	318			318
Other Comprehensive Income (Loss), Net of Tax	17				17
Net income (loss)	1,667					1,667
Preferred shares, ending balance (in shares) at Jun. 30, 2025		0
Ending balance, shareholders' equity at Jun. 30, 2025	$ 32,708	$ 0		498,454	(1,807)	(463,939)
Common shares, ending balance (in shares) at Jun. 30, 2025			2,795,056
Preferred shares, beginning balance (in shares) at Dec. 31, 2025	0	0
Beginning balance, shareholders' equity at Dec. 31, 2025	$ 23,300	$ 0		503,414	(1,811)	(478,303)
Common shares, beginning balance (in shares) at Dec. 31, 2025	3,392,541		3,392,541
Issuance of common shares for reverse stock split fractional shares (in shares)			38,263
Issuance of common shares (in shares)			256,142
Issuance of common shares for at-the-market offering, net	$ 415			415
Issuance of common shares for the settlement of liabilities (in shares)			45,532
Issuance of common shares for settlement of liabilities	61			61
Issuance of common shares for vested restricted stock units (in shares)			34,608
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	325			325
Net income (loss)	(4,106)					(4,106)
Preferred shares, ending balance (in shares) at Mar. 31, 2026		0
Ending balance, shareholders' equity at Mar. 31, 2026	$ 19,995	$ 0		504,215	(1,811)	(482,409)
Common shares, ending balance (in shares) at Mar. 31, 2026			3,767,086
Preferred shares, beginning balance (in shares) at Dec. 31, 2025	0	0
Beginning balance, shareholders' equity at Dec. 31, 2025	$ 23,300	$ 0		503,414	(1,811)	(478,303)
Common shares, beginning balance (in shares) at Dec. 31, 2025	3,392,541		3,392,541
Issuance of common shares (in shares)	1,148,724
Issuance of common shares for at-the-market offering, net	$ 2,500
Issuance of common shares for the settlement of liabilities (in shares)	135,403
Other Comprehensive Income (Loss), Net of Tax	$ 2
Net income (loss)	$ (17,935)
Preferred shares, ending balance (in shares) at Jun. 30, 2026	1,387,117	1,387,117
Ending balance, shareholders' equity at Jun. 30, 2026	$ 16,875	$ 2,677		512,245	(1,809)	(496,238)
Common shares, ending balance (in shares) at Jun. 30, 2026	7,639,893		7,639,893
Preferred shares, beginning balance (in shares) at Mar. 31, 2026		0
Beginning balance, shareholders' equity at Mar. 31, 2026	$ 19,995	$ 0		504,215	(1,811)	(482,409)
Common shares, beginning balance (in shares) at Mar. 31, 2026			3,767,086
Issuance of preferred and common shares for acquisition (in shares)		1,387,117	2,405,300
Issuance of equity instruments for acquisition	$ 7,343	$ 2,677		4,666
Issuance of common shares (in shares)	892,582		892,582
Issuance of common shares for at-the-market offering, net	$ 2,065			2,065
Issuance of common shares for the settlement of liabilities (in shares)			89,871
Issuance of common shares for settlement of liabilities	171			171
Issuance of common shares for vested restricted stock units (in shares)			485,054
Issuance of common shares for vested restricted stock units	231			231
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	897			897
Other Comprehensive Income (Loss), Net of Tax	2				2
Net income (loss)	$ (13,829)					(13,829)
Preferred shares, ending balance (in shares) at Jun. 30, 2026	1,387,117	1,387,117
Ending balance, shareholders' equity at Jun. 30, 2026	$ 16,875	$ 2,677		$ 512,245	$ (1,809)	$ (496,238)
Common shares, ending balance (in shares) at Jun. 30, 2026	7,639,893		7,639,893